Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 289

1.

Post-exposure prophylaxis with rVSV-ZEBOV following exposure to a patient with Ebola virus disease relapse in the UK: an operational, safety and immunogenicity report.

Davis C, Tipton T, Sabir S, Aitken C, Bennett S, Becker S, Evans T, Fehling SK, Gunson R, Hall Y, Jackson C, Johanssen I, Kieny MP, McMenamin J, Spence E, Strecker T, Sykes C, Templeton K, Thorburn F, Peters E, Henao Restrepo AM, White B, Zambon M, Carroll MW, Thomson EC.

Clin Infect Dis. 2019 Nov 30. pii: ciz1165. doi: 10.1093/cid/ciz1165. [Epub ahead of print]

PMID:
31784751
2.

The evaluation of evidence for microspectrophotometry data using functional data analysis.

Aitken C, Chang YT, Buzzini P, Zadora G, Massonnet G.

Forensic Sci Int. 2019 Dec;305:110007. doi: 10.1016/j.forsciint.2019.110007. Epub 2019 Oct 28.

PMID:
31756683
3.

The Elimination of Hepatitis C as a Public Health Threat.

Hellard M, Schroeder SE, Pedrana A, Doyle J, Aitken C.

Cold Spring Harb Perspect Med. 2019 Nov 11. pii: a036939. doi: 10.1101/cshperspect.a036939. [Epub ahead of print]

PMID:
31712223
4.

Surfaceome analysis of Australian epidemic Bordetella pertussis reveals potential vaccine antigens.

Luu LDW, Octavia S, Aitken C, Zhong L, Raftery MJ, Sintchenko V, Lan R.

Vaccine. 2019 Nov 5. pii: S0264-410X(19)31442-2. doi: 10.1016/j.vaccine.2019.10.062. [Epub ahead of print]

PMID:
31703933
5.

Measures of harm reduction service provision for people who inject drugs.

O'Keefe D, Bluthenthal RN, Kral AH, Aitken CK, McCormack A, Dietze PM.

Bull World Health Organ. 2019 Sep 1;97(9):605-611. doi: 10.2471/BLT.18.224089. Epub 2019 Jun 20.

6.

Metagenomic next-generation sequencing aids the diagnosis of viral infections in febrile returning travellers.

Jerome H, Taylor C, Sreenu VB, Klymenko T, Filipe ADS, Jackson C, Davis C, Ashraf S, Wilson-Davies E, Jesudason N, Devine K, Harder L, Aitken C, Gunson R, Thomson EC.

J Infect. 2019 Oct;79(4):383-388. doi: 10.1016/j.jinf.2019.08.003. Epub 2019 Aug 6.

7.

The impact of knowledge of HPV positivity on cytology triage in primary high-risk HPV screening.

Aitken CA, Holtzer-Goor KM, Uyterlinde A, van den Brule AJ, van der Linden HC, Huijsmans CJ, de Kok IM, van Kemenade FJ.

J Med Screen. 2019 Dec;26(4):221-224. doi: 10.1177/0969141319864991. Epub 2019 Jul 25. No abstract available.

PMID:
31342879
8.

The burden of hepatitis E among patients with haematological malignancies: A retrospective European cohort study.

von Felden J, Alric L, Pischke S, Aitken C, Schlabe S, Spengler U, Giordani MT, Schnitzler P, Bettinger D, Thimme R, Xhaard A, Binder M, Ayuk F, Lohse AW, Cornelissen JJ, de Man RA, Mallet V.

J Hepatol. 2019 Sep;71(3):465-472. doi: 10.1016/j.jhep.2019.04.022. Epub 2019 May 18.

PMID:
31108159
9.

The Prison and Transition Health (PATH) Cohort Study: Study Protocol and Baseline Characteristics of a Cohort of Men with a History of Injecting Drug Use Leaving Prison in Australia.

Kirwan A, Curtis M, Dietze P, Aitken C, Woods E, Walker S, Kinner S, Ogloff J, Butler T, Stoové M.

J Urban Health. 2019 Jun;96(3):400-410. doi: 10.1007/s11524-019-00353-5.

10.

Management and treatment of cervical intraepithelial neoplasia in the Netherlands after referral for colposcopy.

Aitken CA, Siebers AG, Matthijsse SM, Jansen EEL, Bekkers RLM, Becker JH, Ter Harmsel B, Roovers JWR, van Kemenade FJ, de Kok IMCM.

Acta Obstet Gynecol Scand. 2019 Jun;98(6):737-746. doi: 10.1111/aogs.13547. Epub 2019 Feb 27.

11.

Reasoning under uncertainty.

Aitken C, Mavridis D.

Evid Based Ment Health. 2019 Feb;22(1):44-48. doi: 10.1136/ebmental-2018-300074. Epub 2019 Jan 24.

PMID:
30679196
12.

Geo-spatial analysis of individual-level needle and syringe coverage in Melbourne, Australia.

O'Keefe D, Wilkinson A, Aitken C, Dietze P.

PLoS One. 2018 Dec 14;13(12):e0209280. doi: 10.1371/journal.pone.0209280. eCollection 2018.

13.

Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis.

Stone J, Fraser H, Lim AG, Walker JG, Ward Z, MacGregor L, Trickey A, Abbott S, Strathdee SA, Abramovitz D, Maher L, Iversen J, Bruneau J, Zang G, Garfein RS, Yen YF, Azim T, Mehta SH, Milloy MJ, Hellard ME, Sacks-Davis R, Dietze PM, Aitken C, Aladashvili M, Tsertsvadze T, Mravčík V, Alary M, Roy E, Smyrnov P, Sazonova Y, Young AM, Havens JR, Hope VD, Desai M, Heinsbroek E, Hutchinson SJ, Palmateer NE, McAuley A, Platt L, Martin NK, Altice FL, Hickman M, Vickerman P.

Lancet Infect Dis. 2018 Dec;18(12):1397-1409. doi: 10.1016/S1473-3099(18)30469-9. Epub 2018 Oct 29.

14.

Māori Men's Experiences of Rehabilitation in the Moana House Therapeutic Community in Aotearoa/New Zealand: A Qualitative Enquiry.

Ashdown JD, Treharne GJ, Neha T, Dixon B, Aitken C.

Int J Offender Ther Comp Criminol. 2019 Apr;63(5):734-751. doi: 10.1177/0306624X18808675. Epub 2018 Oct 22.

PMID:
30348033
15.

Acceptability of prison-based take-home naloxone programmes among a cohort of incarcerated men with a history of regular injecting drug use.

Curtis M, Dietze P, Aitken C, Kirwan A, Kinner SA, Butler T, Stoové M.

Harm Reduct J. 2018 Sep 21;15(1):48. doi: 10.1186/s12954-018-0255-5.

16.

Analysis of time of drug use according to needle and syringe program operating hours in Melbourne, Australia: Effects on individual-level needle and syringe coverage.

O'Keefe D, Aitken C, Scott N, Dietze P.

Drug Alcohol Depend. 2018 Oct 1;191:259-265. doi: 10.1016/j.drugalcdep.2018.07.007. Epub 2018 Aug 22.

PMID:
30153607
17.

Commentary: Likelihood Ratio as Weight of Forensic Evidence: A Closer Look.

Aitken C, Nordgaard A, Taroni F, Biedermann A.

Front Genet. 2018 Jun 22;9:224. doi: 10.3389/fgene.2018.00224. eCollection 2018. No abstract available.

18.

Repeat participation in annual cross-sectional surveys of drug users and its implications for analysis.

Agius PA, Aitken CK, Breen C, Dietze PM.

BMC Res Notes. 2018 Jun 4;11(1):349. doi: 10.1186/s13104-018-3454-y.

19.

Measuring individual-level needle and syringe coverage among people who inject drugs in Myanmar.

O'Keefe D, Aung SM, Pasricha N, Wun T, Linn SK, Lin N, Aitken C, Hughes C, Dietze P.

Int J Drug Policy. 2018 Aug;58:22-30. doi: 10.1016/j.drugpo.2018.04.010. Epub 2018 May 11.

PMID:
29754104
20.

Critical analysis of forensic cut-offs and legal thresholds: A coherent approach to inference and decision.

Biedermann A, Taroni F, Bozza S, Augsburger M, Aitken CGG.

Forensic Sci Int. 2018 Jul;288:72-80. doi: 10.1016/j.forsciint.2018.04.030. Epub 2018 Apr 25.

PMID:
29734052
21.

Bayesian Hierarchical Random Effects Models in Forensic Science.

Aitken CGG.

Front Genet. 2018 Apr 16;9:126. doi: 10.3389/fgene.2018.00126. eCollection 2018. Review.

22.

Volume, nature and potential impact of advertisements on Facebook and YouTube by food brands popular in New Zealand.

Vandevijvere S, Aitken C, Swinburn B.

N Z Med J. 2018 Apr 13;131(1473):14-24.

PMID:
29649193
23.

Recent and Rapid Transmission of HIV Among People Who Inject Drugs in Scotland Revealed Through Phylogenetic Analysis.

Ragonnet-Cronin M, Jackson C, Bradley-Stewart A, Aitken C, McAuley A, Palmateer N, Gunson R, Goldberg D, Milosevic C, Leigh Brown AJ.

J Infect Dis. 2018 May 25;217(12):1875-1882. doi: 10.1093/infdis/jiy130.

24.

The associations of poor psychiatric well-being among incarcerated men with injecting drug use histories in Victoria, Australia.

Cossar R, Stoové M, Kinner SA, Dietze P, Aitken C, Curtis M, Kirwan A, Ogloff JRP.

Health Justice. 2018 Jan 13;6(1):1. doi: 10.1186/s40352-018-0059-4.

25.

Assessing individual-level needle and syringe coverage parameters and the measurement of coverage in Melbourne, Australia: methods and impacts.

O'Keefe D, Scott N, Aitken C, Dietze P.

J Public Health (Oxf). 2018 Sep 1;40(3):e336-e342. doi: 10.1093/pubmed/fdx170.

PMID:
29281039
26.

The Roles of Participants' Differing Background Information in the Evaluation of Evidence.

Aitken C, Nordgaard A.

J Forensic Sci. 2018 Mar;63(2):648-649. doi: 10.1111/1556-4029.13712. Epub 2017 Dec 1. No abstract available.

PMID:
29194595
27.

Yeast eIF4A enhances recruitment of mRNAs regardless of their structural complexity.

Yourik P, Aitken CE, Zhou F, Gupta N, Hinnebusch AG, Lorsch JR.

Elife. 2017 Nov 30;6. pii: e31476. doi: 10.7554/eLife.31476.

28.

The meaning of justified subjectivism and its role in the reconciliation of recent disagreements over forensic probabilism.

Biedermann A, Bozza S, Taroni F, Aitken C.

Sci Justice. 2017 Nov;57(6):477-483. doi: 10.1016/j.scijus.2017.08.005. Epub 2017 Sep 22.

29.

The Association between Intentional Overdose and Same-Sex Sexual Intercourse in a Cohort of People who Inject Drugs in Melbourne, Australia.

O'Keefe D, Bowring A, Aitken C, Dietze P.

Subst Use Misuse. 2018 Apr 16;53(5):755-762. doi: 10.1080/10826084.2017.1363240. Epub 2017 Sep 29.

PMID:
28960149
30.

HCV avidity as a tool for detection of recent HCV infection: Sensitivity depends on HCV genotype.

Shepherd SJ, McDonald SA, Palmateer NE, Gunson RN, Aitken C, Dore GJ, Goldberg DJ, Applegate TL, Lloyd AR, Hajarizadeh B, Grebely J, Hutchinson SJ.

J Med Virol. 2018 Jan;90(1):120-130. doi: 10.1002/jmv.24919. Epub 2017 Sep 18.

PMID:
28843002
31.

Association between universal hepatitis B prison vaccination, vaccine uptake and hepatitis B infection among people who inject drugs.

Palmateer NE, Goldberg DJ, Munro A, Taylor A, Yeung A, Wallace LA, Mitchell A, Shepherd SJ, Gunson RN, Aitken C, Hutchinson SJ.

Addiction. 2018 Jan;113(1):80-90. doi: 10.1111/add.13944. Epub 2017 Aug 21.

PMID:
28710874
32.

How does the use of multiple needles/syringes per injecting episode impact on the measurement of individual level needle and syringe program coverage?

O'Keefe D, McCormack A, Cogger S, Aitken C, Burns L, Bruno R, Stafford J, Butler K, Breen C, Dietze P.

Int J Drug Policy. 2017 Aug;46:99-106. doi: 10.1016/j.drugpo.2017.05.055. Epub 2017 Jun 28.

PMID:
28667880
33.

Comprehensive two-dimensional gas chromatography-mass spectrometry of complex mixtures of anaerobic bacterial metabolites of petroleum hydrocarbons.

Aitken CM, Head IM, Jones DM, Rowland SJ, Scarlett AG, West CE.

J Chromatogr A. 2018 Feb 9;1536:96-109. doi: 10.1016/j.chroma.2017.06.027. Epub 2017 Jun 13.

PMID:
28652003
34.

Longitudinal changes in personal wellbeing in a cohort of people who inject drugs.

Scott N, Carrotte ER, Higgs P, Stoové MA, Aitken CK, Dietze PM.

PLoS One. 2017 May 31;12(5):e0178474. doi: 10.1371/journal.pone.0178474. eCollection 2017.

35.

HIV-1 integrase inhibitor resistance among treatment naïve patients in the West of Scotland.

Bradley-Stewart A, Urcia C, MacLean A, Aitken C, Gunson R.

J Clin Virol. 2017 Jul;92:7-10. doi: 10.1016/j.jcv.2017.04.012. Epub 2017 Apr 23.

PMID:
28494325
36.

Longitudinal analysis of change in individual-level needle and syringe coverage amongst a cohort of people who inject drugs in Melbourne, Australia.

O'Keefe D, Scott N, Aitken C, Dietze P.

Drug Alcohol Depend. 2017 Jul 1;176:7-13. doi: 10.1016/j.drugalcdep.2017.02.013. Epub 2017 Apr 13.

PMID:
28463684
37.

Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL.

Ding W, LaPlant BR, Call TG, Parikh SA, Leis JF, He R, Shanafelt TD, Sinha S, Le-Rademacher J, Feldman AL, Habermann TM, Witzig TE, Wiseman GA, Lin Y, Asmus E, Nowakowski GS, Conte MJ, Bowen DA, Aitken CN, Van Dyke DL, Greipp PT, Liu X, Wu X, Zhang H, Secreto CR, Tian S, Braggio E, Wellik LE, Micallef I, Viswanatha DS, Yan H, Chanan-Khan AA, Kay NE, Dong H, Ansell SM.

Blood. 2017 Jun 29;129(26):3419-3427. doi: 10.1182/blood-2017-02-765685. Epub 2017 Apr 19.

38.

Contribution by CGG Aitken to discussion of Meuwly et al. (2016).

Aitken C.

Forensic Sci Int. 2017 Jul;276:155. doi: 10.1016/j.forsciint.2017.03.012. Epub 2017 Mar 27. No abstract available.

PMID:
28413153
39.

Rps3/uS3 promotes mRNA binding at the 40S ribosome entry channel and stabilizes preinitiation complexes at start codons.

Dong J, Aitken CE, Thakur A, Shin BS, Lorsch JR, Hinnebusch AG.

Proc Natl Acad Sci U S A. 2017 Mar 14;114(11):E2126-E2135. doi: 10.1073/pnas.1620569114. Epub 2017 Feb 21.

40.

The consequences of understanding expert probability reporting as a decision.

Biedermann A, Bozza S, Taroni F, Aitken C.

Sci Justice. 2017 Jan;57(1):80-85. doi: 10.1016/j.scijus.2016.10.005. Epub 2016 Dec 12.

41.

The effects of needle-sharing and opioid substitution therapy on incidence of hepatitis C virus infection and reinfection in people who inject drugs.

Aitken CK, Agius PA, Higgs PG, Stoové MA, Bowden DS, Dietze PM.

Epidemiol Infect. 2017 Mar;145(4):796-801. doi: 10.1017/S0950268816002892. Epub 2016 Dec 8.

PMID:
27927256
42.

HIV-1 drug resistance mutations emerging on darunavir therapy in PI-naive and -experienced patients in the UK.

El Bouzidi K, White E, Mbisa JL, Sabin CA, Phillips AN, Mackie N, Pozniak AL, Tostevin A, Pillay D, Dunn DT; UK HIV Drug Resistance Database; (UKHDRD) and the UK Collaborative HIV Cohort (UK CHIC) Study Steering Committees; UK HIV Drug Resistance Database (UKHDRD) and the UK Collaborative HIV Cohort (UK CHIC) Study Steering Committees.

J Antimicrob Chemother. 2016 Dec;71(12):3487-3494. Epub 2016 Sep 28.

43.

Distribution of cocaine on banknotes in general circulation in England and Wales.

Aitken CGG, Wilson A, Sleeman R, Morgan BEM, Huish J.

Forensic Sci Int. 2017 Jan;270:261-266. doi: 10.1016/j.forsciint.2016.10.017. Epub 2016 Oct 24.

PMID:
27843070
44.

A comment on the PCAST report: Skip the "match"/"non-match" stage.

Morrison GS, Kaye DH, Balding DJ, Taylor D, Dawid P, Aitken CGG, Gittelson S, Zadora G, Robertson B, Willis S, Pope S, Neil M, Martire KA, Hepler A, Gill RD, Jamieson A, de Zoete J, Ostrum RB, Caliebe A.

Forensic Sci Int. 2017 Mar;272:e7-e9. doi: 10.1016/j.forsciint.2016.10.018. Epub 2016 Oct 26.

PMID:
27817943
45.

Eukaryotic translation initiation factor 3 plays distinct roles at the mRNA entry and exit channels of the ribosomal preinitiation complex.

Aitken CE, Beznosková P, Vlčkova V, Chiu WL, Zhou F, Valášek LS, Hinnebusch AG, Lorsch JR.

Elife. 2016 Oct 26;5. pii: e20934. doi: 10.7554/eLife.20934.

46.

Longitudinal changes in psychological distress in a cohort of people who inject drugs in Melbourne, Australia.

Scott N, Carrotte ER, Higgs P, Cogger S, Stoové MA, Aitken CK, Dietze PM.

Drug Alcohol Depend. 2016 Nov 1;168:140-146. doi: 10.1016/j.drugalcdep.2016.08.638. Epub 2016 Sep 11.

PMID:
27664551
47.

No Evidence That HIV-1 Subtype C Infection Compromises the Efficacy of Tenofovir-Containing Regimens: Cohort Study in the United Kingdom.

White E, Smit E, Churchill D, Collins S, Booth C, Tostevin A, Sabin C, Pillay D, Dunn DT; UK HIV Drug Resistance Database and UK Collaborative HIV Cohort Study.

J Infect Dis. 2016 Nov 1;214(9):1302-1308. Epub 2016 May 24.

48.

Reframing the debate: A question of probability, not of likelihood ratio.

Biedermann A, Bozza S, Taroni F, Aitken C.

Sci Justice. 2016 Sep;56(5):392-396. doi: 10.1016/j.scijus.2016.05.008. Epub 2016 Jul 29.

PMID:
27702458
49.

Individual-level needle and syringe coverage in Melbourne, Australia: a longitudinal, descriptive analysis.

O'Keefe D, Scott N, Aitken C, Dietze P.

BMC Health Serv Res. 2016 Aug 19;16(1):411. doi: 10.1186/s12913-016-1668-z.

50.

Recent trends and patterns in HIV-1 transmitted drug resistance in the United Kingdom.

Tostevin A, White E, Dunn D, Croxford S, Delpech V, Williams I, Asboe D, Pozniak A, Churchill D, Geretti AM, Pillay D, Sabin C, Leigh-Brown A, Smit E; UK HIV Drug Resistance Database.

HIV Med. 2017 Mar;18(3):204-213. doi: 10.1111/hiv.12414. Epub 2016 Aug 1.

Supplemental Content

Loading ...
Support Center